ENTITY
Raffles Medical Group

Raffles Medical Group (RFMD SP)

174
Analysis
Health Care • Singapore
Raffles Medical Group is a leading integrated private healthcare provider in Asia. It operates hospitals and a network of medical and dental clinics, offering a wide range of services including primary, specialist, and tertiary care, as well as health insurance and consumer healthcare products. The company was founded in 1976 and is headquartered in Singapore.
more
•18 Sep 2026 17:55•Syndicated

Singapore Market Roundup (18-Sep-2026): CGS cuts Venture's target price to $18.94 from $21.78.

CGS International cuts Venture's target price to $18.94. Goldman Sachs initiates ST Engineering with a 'buy' and $13.20 target.

Share
•10 Sep 2026 18:06•Syndicated

Singapore Market Roundup (10-Sep-2026): RHB views Raffles Medical's 52-week low as a buy signal.

RHB views Raffles Medical's 52-week low as a buying chance. Citi gives a 'buy/high risk' rating to CSE Global, while Maybank's Seet is bullish on...

Share
•29 Jul 2026 17:48•Syndicated

Singapore Market Roundup (29-Jul-2026): JP Morgan stays 'underweight' on Seatrium amid profit

JP Morgan stays 'underweight' on Seatrium; UOBKH downgrades Aztech to 'hold' amid weak outlook; analysts remain positive on CSE Global post-site...

Share
•28 Jul 2026 18:02•Syndicated

Singapore Market Roundup (28-Jul-2026): Analysts stay bullish on CSE Global after recent visit.

Analysts are optimistic on CSE Global post-site visit, positive on iFAST after 2QFY2026 growth, but cautious on Raffles Medical after weak 1HFY2026...

Share
•27 Jul 2026 17:55•Syndicated

Singapore Market Roundup (27-Jul-2026): DBS upgrades StarHub to "buy" on M1 merger benefits.

DBS upgrades StarHub to "buy" on M1 merger prospects, maintains 'buy' on Seatrium with $3 target; Raffles Medical's 1HFY2026 earnings down 9.6% to...

Share
x